Unknown

Dataset Information

Cloaking nanoparticles with protein corona shield for targeted drug delivery.


ABSTRACT: Targeted drug delivery using nanoparticles can minimize the side effects of conventional pharmaceutical agents and enhance their efficacy. However, translating nanoparticle-based agents into clinical applications still remains a challenge due to the difficulty in regulating interactions on the interfaces between nanoparticles and biological systems. Here, we present a targeting strategy for nanoparticles incorporated with a supramolecularly pre-coated recombinant fusion protein in which HER2-binding affibody combines with glutathione-S-transferase. Once thermodynamically stabilized in preferred orientations on the nanoparticles, the adsorbed fusion proteins as a corona minimize interactions with serum proteins to prevent the clearance of nanoparticles by macrophages, while ensuring systema

SUBMITTER: Oh JY 

PROVIDER: S-EPMC6208370 | biostudies-literature | 2018 Oct

REPOSITORIES: biostudies-literature